AU4407493A - Phosphonoacetic esters and acids as anti-inflammatories - Google Patents

Phosphonoacetic esters and acids as anti-inflammatories

Info

Publication number
AU4407493A
AU4407493A AU44074/93A AU4407493A AU4407493A AU 4407493 A AU4407493 A AU 4407493A AU 44074/93 A AU44074/93 A AU 44074/93A AU 4407493 A AU4407493 A AU 4407493A AU 4407493 A AU4407493 A AU 4407493A
Authority
AU
Australia
Prior art keywords
image
inflammatories
acids
phosphonoacetic
esters
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU44074/93A
Other languages
English (en)
Inventor
David John Anderson
Richard Allen Nugent
Stephen Thomas Schlachter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of AU4407493A publication Critical patent/AU4407493A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056—Esters of arylalkanephosphonic acids
    • C07F9/4059—Compounds containing the structure (RY)2P(=X)-(CH2)n-C(=O)-(CH2)m-Ar, (X, Y = O, S, Se; n>=1, m>=0)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F17/00—Metallocenes
    • C07F17/02—Metallocenes of metals of Groups 8, 9 or 10 of the Periodic Table
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4018—Esters of cycloaliphatic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/58—Pyridine rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503—Five-membered rings
    • C07F9/65031—Five-membered rings having the nitrogen atoms in the positions 1 and 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/6512—Six-membered rings having the nitrogen atoms in positions 1 and 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU44074/93A 1992-08-07 1993-06-09 Phosphonoacetic esters and acids as anti-inflammatories Abandoned AU4407493A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US92687992A 1992-08-07 1992-08-07
US926879 1992-08-07
PCT/US1993/005365 WO1994003463A1 (en) 1992-08-07 1993-06-09 Phosphonoacetic esters and acids as anti-inflammatories

Publications (1)

Publication Number Publication Date
AU4407493A true AU4407493A (en) 1994-03-03

Family

ID=25453835

Family Applications (1)

Application Number Title Priority Date Filing Date
AU44074/93A Abandoned AU4407493A (en) 1992-08-07 1993-06-09 Phosphonoacetic esters and acids as anti-inflammatories

Country Status (13)

Country Link
US (2) US5565441A (enExample)
EP (1) EP0654035B1 (enExample)
JP (1) JPH07509712A (enExample)
CN (1) CN1086218A (enExample)
AT (1) ATE157097T1 (enExample)
AU (1) AU4407493A (enExample)
DE (1) DE69313291D1 (enExample)
IL (1) IL106435A0 (enExample)
MX (1) MX9304780A (enExample)
PH (1) PH30956A (enExample)
TW (1) TW226021B (enExample)
WO (1) WO1994003463A1 (enExample)
ZA (1) ZA935380B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2132187C1 (ru) * 1998-11-12 1999-06-27 Антипов Борис Геннадиевич Способ лечения заболеваний кожи и слизистых оболочек и магнитоактивное органическое соединение железа, используемое в нем
WO2004066469A2 (en) * 2003-01-22 2004-08-05 Valence Technology, Inc. Electrolyte for use in phosphate based lithium ion/polymer cells

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3683080A (en) * 1970-08-28 1972-08-08 Procter & Gamble Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue
DE2310450A1 (de) * 1973-03-02 1974-09-05 Henkel & Cie Gmbh Komplexbildner fuer mehrwertige metallionen
DE2360797C2 (de) * 1973-12-06 1985-05-23 Henkel KGaA, 4000 Düsseldorf Pharmazeutische Präparate
FR2531088B1 (fr) * 1982-07-29 1987-08-28 Sanofi Sa Produits anti-inflammatoires derives de l'acide methylenediphosphonique et leur procede de preparation
PH27078A (en) * 1984-12-21 1993-02-01 Procter & Gamble Pharmaceutical compositions containing geminal diphosphonates
US5071840A (en) * 1986-12-19 1991-12-10 Norwich Eaton Pharmaceuticals, Inc. Certain heterocyclic substituted diphosphonate compounds pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism
IL84731A0 (en) * 1986-12-19 1988-05-31 Norwich Eaton Pharma Heterocycle-substituted diphosphonic acids and salts and esters and pharmaceutical compositions containing them
IT1242565B (it) * 1990-09-14 1994-05-16 Marposs Spa Apparecchiatura per il controllo di una pluralita' di pezzi meccanici e relativo metodo di controllo.
EP0521622B1 (en) * 1991-07-03 1997-08-13 PHARMACIA & UPJOHN COMPANY Pyrazolopyrimidine and pyrimidinyl bisphosphonic esters as anti-inflammatories
US5312814A (en) * 1992-12-09 1994-05-17 Bristol-Myers Squibb Co. α-phosphonocarboxylate squalene synthetase inhibitors

Also Published As

Publication number Publication date
WO1994003463A1 (en) 1994-02-17
MX9304780A (es) 1994-02-28
US5565441A (en) 1996-10-15
ZA935380B (en) 1995-01-26
IL106435A0 (en) 1993-11-15
JPH07509712A (ja) 1995-10-26
EP0654035B1 (en) 1997-08-20
PH30956A (en) 1997-12-23
EP0654035A1 (en) 1995-05-24
ATE157097T1 (de) 1997-09-15
DE69313291D1 (de) 1997-09-25
CN1086218A (zh) 1994-05-04
US5643895A (en) 1997-07-01
TW226021B (enExample) 1994-07-01

Similar Documents

Publication Publication Date Title
CA2502856A1 (en) Intermediates for retroviral protease inhibiting compounds
ATE203026T1 (de) Hydroxymethyl-imidazodiazepine und deren ester
HU9400003D0 (en) Pyrazolopyrimidine and pyrimidinyl bisphosphonic esters as anti-inflammatories
GR861760B (en) 1-substituted oxindole-3-carboxamides as anti-inflammatory and analgesic agents
CA2108584A1 (en) Substituted Azetidinones as Anti-Inflammatory and Antidegenerative Agents
IE780552L (en) Esters and thiolesters of amino acids
AU7675896A (en) Sulfur containing di-tert-butylphenol compounds useful as anti-inflammatory agents
PH30956A (en) Phosphonoacetic esters and acids as anti-inflammatories.
NO177055C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-oksetanoner
IE41831L (en) W-(3`-benzoyl) phenyl-alkanoic or alkenoic acids.
AU7119187A (en) Ester prodrugs of dopamine-beta-hydroxylase inhibitors
JPS5519214A (en) 2-acyl-6-aminomethylphenol derivative and its preparation
JPS6492A (en) Novel glycerin derivative, production thereof, hypotensor containing said derivative
AU1843197A (en) Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
IE792328L (en) Derivatives of dihydropyrrole and tetrahydropyridine.
HK11486A (en) Substituted fluorophenols and their use in the preparation of liquid crystal esters
IE851486L (en) CYCLOPENTA (b) THIOPHENE-6-CARBOXYLIC ACIDS
NZ238124A (en) Heterocyclylalkylphosphonic acid and ester derivatives and pharmacueitcal compositions
IL105938A (en) Process for preparing tetronic acid alkyl esters
MX9606520A (es) Mezclas fungicidas.
AU1508592A (en) Sweetening agents derived from l-glutamic acid and their method of preparation
EP0305837A3 (en) Thiono-phosphonic-acid ester
IE790841L (en) Omega - (1,3-dithiolan-2-imino) substituted acetic acids
JPS6426532A (en) Novel unsaturated fatty acid derivative
IE800978L (en) Esters of 2-(6-methoxy-2-naphthyl)-1-propanol